Thailanstatin analogs
The invention provides novel cytotoxic compounds and cytotoxic conjugates comprising these cytotoxic compounds and cell-binding agents. More specifically, this invention relates to novel thailanstatin A analogs, useful as cytotoxic small molecule toxins in antibody-drug conjugates (ADCs). The present invention further relates to compositions including these cytotoxic compounds and ADCs, and methods for using these toxins and ADCs to treat pathological conditions including cancer.
1. A compound of Formula (I):
wherein:
R is selected from the group consisting of: —(CH 2 ) n —R 1 ; 5 to 6 membered heteroaryl, where heteroaryl is optionally substituted with one or more of halogen, —CF 3 , —C 1-6 alkyl, and —O—C 1-6 alkyl;
—C(R 2 )═N—R 3 ; —CH(CF 3 )NH(CH 2 ) m CH 3 ; —C(R a R b )NH(CH 2 ) m CH 3 ;
—C(halogen)═CH(CH 2 ) m CH 3 ; —SO 2 —NH(CH 2 ) m CH 3 ; —O(CO)-aryl; —O(CO)-heteroaryl;
—NR a R b ; and —NH-heteroaryl;
wherein R 1 is —O—CR a R b (CH 2 ) m CH 3 or —N—CR a R b (CH 2 ) m CH 3 ;
wherein R a and R b , together with the atoms to which they are joined, form a C 3-10 heterocyclyl ring;
R 2 is —CN or —NH(CH 2 ) m CH 3 ;
R 3 is —(CH 2 ) m CH 3 or —O—(CH 2 ) m CH 3 ;
X is —H or —CH 3 ;
each n is independently 1, 2, or 3; and
each m is independently 0, 1, 2, or 3;
or a pharmaceutically acceptable salt thereof.
2. The compound according to claim 1 , wherein R is selected from the group consisting of:
3. The compound of claim 1 , wherein the compound is selected from the group consisting of:
4. A compound of Formula (I):
wherein:
R is selected from the group consisting of:
X is —H or —CH 3 ;
or a pharmaceutically acceptable salt thereof.